Friday 6 November 2026
Export ELUT’s income statement to Excel — free account
Elutia Inc.
ELUT Healthcare Medical Devices
Elutia Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.3 million, down 15.0% from fiscal 2024.
- Revenue
- −11.7%
- EPS
- +26.1%
- Free cash flow
- −2.52%
Quarter to June 2026, against a year earlier
0.85
0.10
+13.33%
Follow ELUT
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 5 | 1 |
+8 more TTM periods Free account |
| (454.01%) | (822.31%) | (654.34%) | 62.39% | ||
| 152.89% | 121.21% | 123.51% | (67.48%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
310.30% | 206.22% | 183.23% | 125.60% | |
Average Days of Receivables |
399.77 | 451.74 | 432.90 | 204.40 | |
Free Cash Flow per Share |
(1.04) | (1.07) | (1.13) | (0.79) | |
Free Cash Flow |
(46.03) | (45.82) | (46.69) | (33.37) | |
Capital Expenditures |
(2.03) | (2.06) | (1.88) | (1.12) | |
| Other line items | |||||
Cash ROIC |
(129.14%) | (89.81%) | (72.92%) | 254.84% | |
Accounts Receivable Turnover |
1.17 | 1.12 | 1.14 | 1.85 | |
Accounts Payable Turnover |
1.07 | 1.30 | 1.27 | 0.49 | |
Inventory Turnover |
1.30 | 1.57 | 2.51 | 1.02 | |
Average Days of Payables |
251.43 | 259.66 | 306.95 | 838.83 | |
Days of Inventory on Hand |
188.62 | 178.27 | 167.67 | 255.67 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
56.06% | 42.27% | 33.86% | 21.20% | |
Selling, General and Administrative Expense of Revenue |
178.77% | 174.21% | 169.57% | 108.75% | |
Share Based Compensation of Revenue |
38.65% | 39.61% | 42.41% | 38.30% | |
Interest Coverage |
— | 164.48 | (205.43) | 30.74 | |
Operating CF/Net income |
(0.74) | (0.76) | (0.74) | 1.23 | |
Depreciation/Fixed assets |
0.69 | 0.75 | 1.11 | 1.63 | |
Capex/Depreciation |
(1.01) | (0.94) | (0.67) | (0.33) | |
Revenue per Share |
0.27 | 0.29 | 0.30 | 0.34 | |
Operating CF per Share |
(0.99) | (1.02) | (1.08) | (0.76) | |
Capex per Share |
(0.05) | (0.05) | (0.05) | (0.03) | |
Capex to Sales |
0.17 | 0.17 | 0.15 | 0.08 |
Columns are period end dates · fundamentals updated 26 Oct 2026